336 related articles for article (PubMed ID: 10843736)
1. Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: synergy with dexamethasone.
Richards CD; Langdon C; Deschamps P; Pennica D; Shaughnessy SG
Cytokine; 2000 Jun; 12(6):613-21. PubMed ID: 10843736
[TBL] [Abstract][Full Text] [Related]
2. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
Malaval L; Liu F; Vernallis AB; Aubin JE
J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050
[TBL] [Abstract][Full Text] [Related]
3. Expression of leukemia inhibitory factor (LIF)/interleukin-6 family cytokines and receptors during in vitro osteogenesis: differential regulation by dexamethasone and LIF.
Liu F; Aubin JE; Malaval L
Bone; 2002 Jul; 31(1):212-9. PubMed ID: 12110437
[TBL] [Abstract][Full Text] [Related]
4. The IL-6 family cytokines, interleukin-6, interleukin-11, oncostatin M, and leukemia inhibitory factor, enhance mast cell growth through fibroblast-dependent pathway in mice.
Gyotoku E; Morita E; Kameyoshi Y; Hiragun T; Yamamoto S; Hide M
Arch Dermatol Res; 2001 Nov; 293(10):508-14. PubMed ID: 11820727
[TBL] [Abstract][Full Text] [Related]
5. LIF, but not IL-6, regulates osteoprogenitor differentiation in rat calvaria cell cultures: modulation by dexamethasone.
Malaval L; Gupta AK; Liu F; Delmas PD; Aubin JE
J Bone Miner Res; 1998 Feb; 13(2):175-84. PubMed ID: 9495510
[TBL] [Abstract][Full Text] [Related]
6. The mouse mammary tumor cell line, MMT060562, produces prostaglandin E2 and leukemia inhibitory factor and supports osteoclast formation in vitro via a stromal cell-dependent pathway.
Akatsu T; Ono K; Katayama Y; Tamura T; Nishikawa M; Kugai N; Yamamoto M; Nagata N
J Bone Miner Res; 1998 Mar; 13(3):400-8. PubMed ID: 9525340
[TBL] [Abstract][Full Text] [Related]
7. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
[TBL] [Abstract][Full Text] [Related]
8. Cloning and biological activity of murine oncostatin M.
Hara T; Ichihara M; Yoshimura A; Miyajima A
Leukemia; 1997 Apr; 11 Suppl 3():449-50. PubMed ID: 9209421
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoids inhibit oncostatin M-induced phospholipase A2 gene expression in human hepatoma cells.
Haselmann J; Goppelt-Struebe M
Cytokine; 1997 Mar; 9(3):199-205. PubMed ID: 9126708
[TBL] [Abstract][Full Text] [Related]
10. Oncostatin M is a differentiation factor for myeloid leukemia cells.
Bruce AG; Hoggatt IH; Rose TM
J Immunol; 1992 Aug; 149(4):1271-5. PubMed ID: 1380037
[TBL] [Abstract][Full Text] [Related]
11. Activation of Shc1 Allows Oncostatin M to Induce RANKL and Osteoclast Formation More Effectively Than Leukemia Inhibitory Factor.
Persson E; Souza PPC; Floriano-Marcelino T; Conaway HH; Henning P; Lerner UH
Front Immunol; 2019; 10():1164. PubMed ID: 31191537
[No Abstract] [Full Text] [Related]
12. Leukemia inhibitory factor and oncostatin M stimulate collagenase-3 expression in osteoblasts.
Varghese S; Yu K; Canalis E
Am J Physiol; 1999 Mar; 276(3):E465-71. PubMed ID: 10070011
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of chemokines by leukemia inhibitory factor, interleukin-6 and oncostatin M.
Hartner A; Goppelt-Struebe M; Hocke GM; Sterzel RB
Kidney Int; 1997 Jun; 51(6):1754-60. PubMed ID: 9186863
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro.
Saleh H; Eeles D; Hodge JM; Nicholson GC; Gu R; Pompolo S; Gillespie MT; Quinn JM
Endocrinology; 2011 May; 152(5):1911-22. PubMed ID: 21363931
[TBL] [Abstract][Full Text] [Related]
15. Cytokines involving gp130 in signal transduction suppressed growth of a mouse hybridoma cell line and enhanced its antibody production.
Terada S; Suzuki E; Ueda H; Makishima F
Cytokine; 1996 Dec; 8(12):889-94. PubMed ID: 9050746
[TBL] [Abstract][Full Text] [Related]
16. The gp 130 family cytokines IL-6, LIF and OSM but not IL-11 can reverse the anti-proliferative effect of dexamethasone on human myeloma cells.
Juge-Morineau N; François S; Puthier D; Godard A; Bataille R; Amiot M
Br J Haematol; 1995 Jul; 90(3):707-10. PubMed ID: 7647014
[TBL] [Abstract][Full Text] [Related]
17. Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells.
Klausen P; Pedersen L; Jurlander J; Baumann H
Oncogene; 2000 Jul; 19(32):3675-83. PubMed ID: 10951574
[TBL] [Abstract][Full Text] [Related]
18. Oncostatin M synergises with house dust mite proteases to induce the production of PGE(2) from cultured lung epithelial cells.
Knight DA; Asokananthan N; Watkins DN; Misso NL; Thompson PJ; Stewart GA
Br J Pharmacol; 2000 Oct; 131(3):465-72. PubMed ID: 11015296
[TBL] [Abstract][Full Text] [Related]
19. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway.
Ray DW; Ren SG; Melmed S
J Clin Invest; 1996 Apr; 97(8):1852-9. PubMed ID: 8621768
[TBL] [Abstract][Full Text] [Related]
20. Are LIF and related cytokines functionally equivalent?
Piquet-Pellorce C; Grey L; Mereau A; Heath JK
Exp Cell Res; 1994 Aug; 213(2):340-7. PubMed ID: 8050491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
